Trial Profile
Clinical Trials Insight: 700026993
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Oct 2008
Price :
$35
*
At a glance
- Drugs CH 1504 (Primary)
- Indications Psoriasis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Chelsea Therapeutics
- 14 Sep 2007 New trial record.